Department Hematopoiesis, Sanquin Research, and Landsteiner Laboratory, Amsterdam University Medical Centre, 1066CX Amsterdam, The Netherlands.
Department Blood Cell Research, Sanquin Research and Landsteiner Laboratory, Academic Medical Centre, University of Amsterdam,1066CX Amsterdam, The Netherlands.
Int J Mol Sci. 2020 Jan 31;21(3):967. doi: 10.3390/ijms21030967.
Megakaryopoiesis is the process during which megakaryoblasts differentiate to polyploid megakaryocytes that can subsequently shed thousands of platelets in the circulation. Megakaryocytes accumulate mRNA during their maturation, which is required for the correct spatio-temporal production of cytoskeletal proteins, membranes and platelet-specific granules, and for the subsequent shedding of thousands of platelets per cell. Gene expression profiling identified the RNA binding protein ATAXIN2 (ATXN2) as a putative novel regulator of megakaryopoiesis. expression is high in CD34/CD41 megakaryoblasts and sharply decreases upon maturation to megakaryocytes. ATXN2 associates with DDX6 suggesting that it may mediate repression of mRNA translation during early megakaryopoiesis. Comparative transcriptome and proteome analysis on megakaryoid cells (MEG-01) with differential expression identified ATXN2 dependent gene expression of mRNA and protein involved in processes linked to hemostasis. Mice deficient for Atxn2 did not display differences in bleeding times, but the expression of key surface receptors on platelets, such as ITGB3 (carries the CD61 antigen) and CD31 (PECAM1), was deregulated and platelet aggregation upon specific triggers was reduced.
巨核细胞生成是巨核母细胞分化为多倍体巨核细胞的过程,随后巨核细胞可以在循环中释放数千个血小板。巨核细胞在成熟过程中积累 mRNA,这对于正确的细胞骨架蛋白、膜和血小板特异性颗粒的时空产生以及随后每个细胞释放数千个血小板是必需的。基因表达谱分析将 RNA 结合蛋白 ATAXIN2(ATXN2)鉴定为巨核细胞生成的潜在新调节因子。 在 CD34/CD41 巨核母细胞中表达水平高,而在成熟为巨核细胞时急剧下降。ATXN2 与 DDX6 结合,表明它可能在早期巨核细胞生成过程中介导 mRNA 翻译的抑制。对差异表达的巨核样细胞(MEG-01)进行比较转录组和蛋白质组分析,确定了 ATXN2 依赖的与止血相关过程相关的 mRNA 和蛋白质的基因表达。Atxn2 缺失的小鼠在出血时间上没有差异,但血小板上的关键表面受体,如 ITGB3(携带 CD61 抗原)和 CD31(PECAM1)的表达失调,特定触发时的血小板聚集减少。